NCT04916145

An Investigator-initiated, Explorative Trial Evaluating the Effect of SAT-008 in Healthy Adults

A Single-center, Randomized, Open Label, No-treatment Controlled, Digital Device Study to Evaluate the Efficacy, Safety and Feasibility of SAT-008 in Healthy Adults

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 42 (actual)
• Sponsor: Seoul National University Bundang Hospital · Academic / Other
• Sex: All
• Age: 19 Years – 50 Years
• Healthy volunteers: Accepted

Summary

The purpose of this exploratory study is to evaluate the efficacy, safety, and feasibility of a novel digital device called SAT-008 in healthy adults.

Detailed description

This clinical study was designed as a single institution, open, controlled, and investigator-led clinical trial to evaluate the efficacy, safety, and feasibility of a novel digital device called SAT-008 in healthy adults.

Conditions

• Allergy and Immunology

Interventions

Type	Name	Description
DEVICE	SAT-008	SAT-008 is a digital device containing several types of activities related to the immune function of adults.

Timeline

• Start date: 2020-10-08
• Primary completion: 2021-01-25
• Completion: 2021-01-25
• First posted: 2021-06-07
• Last updated: 2021-06-07

Locations

1 site across 1 country: South Korea